載入...
Inhibition of integrin β3, a binding partner of kallistatin, leads to reduced viability, invasion and proliferation in NCI-H446 cells
BACKGROUND: Kallistatin is a serine proteinase inhibitor and heparin-binding protein. It is considered an endogenous angiogenic inhibitor. In addition, multiple studies demonstrated that kallistatin directly inhibits cancer cell growth. However, the molecular mechanisms underlying these effects rema...
Na minha lista:
| 發表在: | Cancer Cell Int |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
BioMed Central
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5134261/ https://ncbi.nlm.nih.gov/pubmed/27980455 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-016-0365-7 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|